1-3 of 3
Lewis Silverman
Close
Sort by
Journal Articles

Stem and progenitor cells in myelodysplastic syndromes show aberrant stage-specific expansion and harbor genetic and epigenetic alterations

Britta Will, Li Zhou, Thomas O. Vogler, Susanna Ben-Neriah, Carolina Schinke, Roni Tamari, Yiting Yu, Tushar D. Bhagat, Sanchari Bhattacharyya, Laura Barreyro, Christoph Heuck, Yonkai Mo, Samir Parekh, Christine McMahon, Andrea Pellagatti, Jacqueline Boultwood, Cristina Montagna, Lewis Silverman, Jaroslaw Maciejewski, John M. Greally, B. Hilda Ye, Alan F. List, Christian Steidl, Ulrich Steidl, Amit Verma
Journal: Blood
Blood (2012) 120 (10): 2076–2086.
https://doi.org/10.1182/blood-2011-12-399683
Published: 2012
Includes: Supplemental data
Journal Articles

A Phase I Study of the Proteasome Inhibitor Bortezomib in Patients with Myelofibrosis.

Giovanni Barosi, MD, Elisabetta Gattoni, MD, Tiziano Barbui, MD, Alessandro M. Vannucchi, MD, Alessandro Rambaldi, MD, Lewis Silverman, MD, Judith Goldberg, MD, Roberto Marchioli, MD, Ronald Hoffman, MD
Journal: Blood
Blood (2007) 110 (11): 3540.
https://doi.org/10.1182/blood.V110.11.3540.3540
Published: 2007
Journal Articles

Tracking the MDS Clone in Peripheral Blood (PB) Cells from Patients (pts) with Myelodysplastic Syndrome (MDS) Undergoing Azacitidine (AZAC)-Based Therapy.

Amanda Cozza, MSc, Lewis Silverman, M.D., Rosalie Odchimar-Reissig, R.N., Ilene Schulman, R.N, Svetlana Zinzar, Ph.D., Vesna Najfeld, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 4600.
https://doi.org/10.1182/blood.V110.11.4600.4600
Published: 2007